Company intelligence / Profile preview

EUDRAC

Heidelberg, Baden-Württemberg, Germanyeudrac.com ↗

Ownership: Private
Development stage: Other

Overview

EUDRAC was a specialized European consultancy providing regulatory affairs and pharmacovigilance support to pharmaceutical and medical device companies throughout product development, registration, market launch, and post-marketing activities across the EU. The company was acquired by QbD Group in November 2022 and now operates as QbD Ltd.

Industry: Consulting

Partnerships

Now part of the broader QbD Group network post-acquisition

Beyond the preview

Go deeper on EUDRAC.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on EUDRAC.

Explore the full profile